Idexx Laboratories Inc.
Congress has disclosed 19 buys and 20 sells of IDXX (Idexx Laboratories Inc.) in official financial disclosures, each linked to its original filing. A transparency record — not investment advice.
Activity Congressional Activity
Round-trip watch Still on the books
Members who disclosed buying IDXX and have not disclosed selling, versus their own entry (the most recent disclosed buy). "Open" means no disclosed sale — never "still holds" — and the % is unrealised, on paper. Not investment advice.
| Member | Entry (last buy) | Entry price | Now | vs entry | Status |
|---|---|---|---|---|---|
| Rohit Khanna | 2026-04-13 | $574.00 | $551.21 | -4.0% | ↩ near entry |
| Byron Donalds | 2025-09-04 | $640.44 | $551.21 | -13.9% | underwater |
| Rob Bresnahan | 2025-05-15 | $511.99 | $551.21 | +7.7% | in profit |
Price as of 2026-10-30. Counted open while disclosed buys outnumber disclosed sells; tracks the price, not exact position size (amounts are ranges).
Fundamentals · FY2026 Valuation
Standard valuation multiples from SEC-reported GAAP financials (trailing twelve months), each compared to the median for Health. We use reported GAAP, not forward or adjusted earnings, so our figures can sit higher than sites that do — especially for companies with falling profit. Relative context — not a target price or investment advice.
how it's calculated
how it's calculated
how it's calculated
Legislation Related Legislation
Recent bills in this stock's sector (Health). Sector-level context from Congress.gov — a bill names a policy area, not this company specifically.
| Bill | Title | Policy area | Latest action |
|---|---|---|---|
| HR 10887 | Protecting Consumer Access to Generic Drugs Act of 2026 | Health | 2026-10-22 |
| HR 10874 | Medicare Low Income Subsidy Equality Act of 2026 | Health | 2026-10-22 |
| HR 10858 | CARE for Blood Cancer Act of 2026 | Health | 2026-10-22 |
| HR 10810 | National Patient Safety Board Act of 2026 | Health | 2026-10-15 |
| HR 10824 | Stroke Education and EMS Care Improvement Act of 2026 | Health | 2026-10-15 |
39 trades Recent Congressional Trades
Two things to watch per trade: the disclosure lag (how many days passed before the trade was made public) and the price move in that window (how the stock moved during those non-public days). A sell followed by a price drop, or a buy followed by a rise, means well-timed trading — visible here in the open. Note: the Score measures how notable a trade is, not whether it made money — the price move is shown for context and isn't part of it.
| Politician | Chamber | Type | Owner | Date | Disclosure lag | Price move in that window | Amount | Score | Source |
|---|---|---|---|---|---|---|---|---|---|
| Rohit Khanna | House | BUY OCR ◆ insider divergence · moderate | Spouse | 2026-04-13 | 21 days | -1.9% | $1K–$15K | 12.9 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider divergence · moderate | Child | 2026-03-30 | 3 days | +2.2% | $15K–$50K | 30.2 | ↗ filing |
| April McClain Delaney | House | SELL ◆ insider convergence · moderate | Child | 2026-01-13 | 19 days | -6.1% | $1K–$15K <0.1% of NW |
0.4 | ↗ filing |
| April McClain Delaney | House | SELL ◆ insider convergence | Child | 2025-12-02 | 30 days | -7.7% | $1K–$15K <0.1% of NW |
0.3 | ↗ filing |
| April McClain Delaney | House | SELL ◆ insider convergence | Child | 2025-10-29 | 3 days | +0.3% | $1K–$15K <0.1% of NW |
0.3 | ↗ filing |
| April McClain Delaney | House | SELL ◆ insider convergence | Child | 2025-10-16 | 16 days | -1.2% | $1K–$15K <0.1% of NW |
0.4 | ↗ filing |
| Byron Donalds | House | BUY ◆ insider divergence · moderate | Self · Moran Wealth IRA | 2025-09-04 | 27 days | -3.2% | $1K–$15K 0.3% of NW |
64.8 | ↗ filing |
| Byron Donalds | House | BUY ◆ insider divergence · moderate | Spouse · Moran Wealth IRA | 2025-09-04 | 27 days | -3.2% | $1K–$15K 0.3% of NW |
64.8 | ↗ filing |
| April McClain Delaney | House | SELL ◆ insider convergence · moderate | Child | 2025-08-07 | 25 days | -0.5% | $1K–$15K <0.1% of NW |
0.6 | ↗ filing |
| April McClain Delaney | House | SELL ◆ insider convergence · moderate | Child | 2025-08-01 | 31 days | +20.8% | $1K–$15K <0.1% of NW |
0.7 | ↗ filing |
| April McClain Delaney | House | SELL ◆ insider convergence · moderate | Child | 2025-07-09 | 23 days | -0.9% | $1K–$15K <0.1% of NW |
0.9 | ↗ filing |
| Rob Bresnahan | House | BUY ◆ insider divergence · moderate | Self · JP Morgan Brokerage Account | 2025-05-15 | 0 days | 0.0% | $1K–$15K 0.2% of NW |
14.0 | ↗ filing |
| Jefferson Shreve | House | SELL ◆ insider convergence · moderate | Self · CRT - Standard Unit Trust | 2025-05-12 | 3 days | +0.5% | $100K–$250K <0.1% of NW |
89.6 | ↗ filing |
| April McClain Delaney | House | BUY ◆ insider divergence · moderate | Child | 2025-04-09 | 22 days | +18.7% | $1K–$15K <0.1% of NW |
4.1 | ↗ filing |
| Rob Bresnahan | House | SELL ◆ insider convergence · moderate | Self · JP Morgan Brokerage Account | 2025-04-08 | 0 days | 0.0% | $1K–$15K 0.2% of NW |
28.5 | ↗ filing |
| April McClain Delaney | House | BUY ◆ insider divergence · moderate | Child | 2025-04-07 | 24 days | +24.4% | $1K–$15K <0.1% of NW |
7.3 | ↗ filing |
| April McClain Delaney | House | BUY ◆ insider divergence · moderate | Child | 2025-04-04 | 27 days | +19.7% | $1K–$15K <0.1% of NW |
12.9 | ↗ filing |
| April McClain Delaney | House | BUY ◆ insider divergence · moderate | Child | 2025-04-01 | 30 days | +12.6% | $1K–$15K <0.1% of NW |
25.8 | ↗ filing |
| April McClain Delaney | House | BUY ◆ insider divergence · moderate | Child | 2025-03-14 | 18 days | +0.8% | $1K–$15K <0.1% of NW |
66.3 | ↗ filing |
| Rob Bresnahan | House | BUY ◆ insider divergence | Self · JP Morgan Brokerage Account | 2025-02-25 | 0 days | 0.0% | $1K–$15K 0.2% of NW |
67.0 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider divergence · moderate | Child | 2024-12-18 | 20 days | +4.0% | $1K–$15K | 15.7 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider divergence | Child | 2024-08-05 | 31 days | — | $1K–$15K | 22.3 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider divergence · moderate | Child | 2024-02-13 | 21 days | — | $1K–$15K | 40.4 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider divergence · moderate | Child | 2023-08-29 | 7 days | — | $1K–$15K | 75.9 | ↗ filing |
| Peter Meijer | House | SELL | Self | 2021-02-16 | 3 days | — | $1K–$15K | 75.9 | ↗ filing |
| Gilbert Cisneros | House | SELL | Self | 2020-10-09 | 25 days | — | $1K–$15K 0.1% of NW |
6.8 | ↗ filing |
| Gilbert Cisneros | House | SELL | Self | 2020-08-11 | 31 days | — | $1K–$15K 0.1% of NW |
8.6 | ↗ filing |
| Gilbert Cisneros | House | SELL | Self | 2020-06-10 | 29 days | — | $1K–$15K 0.1% of NW |
10.6 | ↗ filing |
| Gilbert Cisneros | House | BUY | Self | 2020-04-09 | 29 days | — | $1K–$15K 0.1% of NW |
15.7 | ↗ filing |
| Gilbert Cisneros | House | SELL | Self | 2019-06-03 | 4 days | — | $1K–$15K 0.1% of NW |
22.3 | ↗ filing |
| Gilbert Cisneros | House | BUY | Self | 2019-02-27 | 8 days | — | $1K–$15K 0.1% of NW |
40.4 | ↗ filing |
| Gilbert Cisneros | House | BUY | Self | 2019-02-26 | 9 days | — | $1K–$15K 0.1% of NW |
75.9 | ↗ filing |
| Lamar Smith | House | SELL | Self | 2015-06-02 | 29 days | — | $1K–$15K | 10.6 | ↗ filing |
| Michael Conaway | House | SELL | Spouse | 2015-02-10 | 3 days | — | $1K–$15K | 40.4 | ↗ filing |
| Michael Conaway | House | SELL | Spouse | 2015-02-09 | 3 days | — | $1K–$15K | 75.9 | ↗ filing |
| Lamar Smith | House | BUY | Self | 2014-10-06 | 29 days | — | $1K–$15K | 15.7 | ↗ filing |
| Lamar Smith | House | SELL | Self | 2014-04-02 | 34 days | — | $1K–$15K | 22.3 | ↗ filing |
| Lamar Smith | House | SELL | Self | 2014-03-11 | 21 days | — | $1K–$15K | 40.4 | ↗ filing |
| Lamar Smith | House | SELL | Self | 2014-02-18 | 14 days | — | $1K–$15K | 75.9 | ↗ filing |
Corporate insiders · SEC Form 4 Insider Activity
What the company's own officers and directors did in IDXX — open-market purchases and sales from SEC Form 4 filings (option exercises, grants and tax withholding are excluded). This is context for the congressional activity above, never a buy/sell signal, and the two datasets are kept separate on purpose. Does convergence mean anything? →
Of the congressional trades in IDXX, 9 coincided with corporate insiders moving the same way within 60 days, and 15 with insiders moving the opposite way. This is co-occurrence only — whether it carries any edge is tested honestly on the convergence page.
| Date | Insider | Role | Type | Size | Source |
|---|---|---|---|---|---|
| 2026-09-04 | Kingsley Lawrence D | Director | SELL | $1.2M | ↗ EDGAR |
| 2026-03-03 | Hunt Nimrata | Other | SELL | $1.1M | ↗ EDGAR |
| 2026-02-26 | Hunt Nimrata | Other | SELL | $1.8M | ↗ EDGAR |
| 2026-02-26 | MAZELSKY JONATHAN JAY | C-suite | SELL | $834K | ↗ EDGAR |
| 2026-02-26 | MAZELSKY JONATHAN JAY | C-suite | SELL | $713K | ↗ EDGAR |
| 2026-02-26 | MAZELSKY JONATHAN JAY | C-suite | SELL | $1.1M | ↗ EDGAR |
| 2026-02-26 | MAZELSKY JONATHAN JAY | C-suite | SELL | $765K | ↗ EDGAR |
| 2026-02-26 | MAZELSKY JONATHAN JAY | C-suite | SELL | $727K | ↗ EDGAR |
| 2026-02-26 | MAZELSKY JONATHAN JAY | C-suite | SELL | $976K | ↗ EDGAR |
| 2026-02-26 | MAZELSKY JONATHAN JAY | C-suite | SELL | $882K | ↗ EDGAR |
| 2026-02-26 | MAZELSKY JONATHAN JAY | C-suite | SELL | $1.9M | ↗ EDGAR |
| 2026-02-26 | MAZELSKY JONATHAN JAY | C-suite | SELL | $2.4M | ↗ EDGAR |
| 2026-02-26 | MAZELSKY JONATHAN JAY | C-suite | SELL | $1.9M | ↗ EDGAR |
| 2026-02-26 | MAZELSKY JONATHAN JAY | C-suite | SELL | $793K | ↗ EDGAR |
| 2026-02-26 | MAZELSKY JONATHAN JAY | C-suite | SELL | $662K | ↗ EDGAR |
| 2026-02-26 | MAZELSKY JONATHAN JAY | C-suite | SELL | $1.7M | ↗ EDGAR |
| 2026-02-17 | Vandebroek Sophie V. | Director | SELL | $594K | ↗ EDGAR |
| 2026-02-17 | Vandebroek Sophie V. | Director | SELL | $326K | ↗ EDGAR |
| 2026-02-17 | Erickson Michael G | Other | SELL | $284K | ↗ EDGAR |
| 2026-02-17 | Erickson Michael G | Other | SELL | $128K | ↗ EDGAR |
| 2026-02-17 | Erickson Michael G | Other | SELL | $807K | ↗ EDGAR |
| 2026-02-17 | Erickson Michael G | Other | SELL | $1.7M | ↗ EDGAR |
| 2026-02-17 | Erickson Michael G | Other | SELL | $433K | ↗ EDGAR |
| 2026-02-17 | Erickson Michael G | Other | SELL | $25K | ↗ EDGAR |
| 2026-02-10 | FENNELL GEORGE | Other | SELL | $727K | ↗ EDGAR |
Combined timeline — Congress & insiders
Both sets of trades on one timeline, newest first, so you can see when they lined up. Congress vs ◆ insider.
| Date | Who | Type | Size | |
|---|---|---|---|---|
| ◆ insider | 2026-09-04 | Kingsley Lawrence D Director | SELL | $1.2M |
| Congress | 2026-04-13 | Rohit Khanna | BUY | $1K–$15K |
| Congress | 2026-03-30 | Rohit Khanna | BUY | $15K–$50K |
| ◆ insider | 2026-03-03 | Hunt Nimrata Other | SELL | $1.1M |
| ◆ insider | 2026-02-26 | Hunt Nimrata Other | SELL | $1.8M |
| ◆ insider | 2026-02-26 | MAZELSKY JONATHAN JAY C-suite | SELL | $834K |
| ◆ insider | 2026-02-26 | MAZELSKY JONATHAN JAY C-suite | SELL | $713K |
| ◆ insider | 2026-02-26 | MAZELSKY JONATHAN JAY C-suite | SELL | $1.1M |
| ◆ insider | 2026-02-26 | MAZELSKY JONATHAN JAY C-suite | SELL | $765K |
| ◆ insider | 2026-02-26 | MAZELSKY JONATHAN JAY C-suite | SELL | $727K |
| ◆ insider | 2026-02-26 | MAZELSKY JONATHAN JAY C-suite | SELL | $976K |
| ◆ insider | 2026-02-26 | MAZELSKY JONATHAN JAY C-suite | SELL | $882K |
| ◆ insider | 2026-02-26 | MAZELSKY JONATHAN JAY C-suite | SELL | $1.9M |
| ◆ insider | 2026-02-26 | MAZELSKY JONATHAN JAY C-suite | SELL | $2.4M |
| ◆ insider | 2026-02-26 | MAZELSKY JONATHAN JAY C-suite | SELL | $1.9M |
| ◆ insider | 2026-02-26 | MAZELSKY JONATHAN JAY C-suite | SELL | $793K |
| ◆ insider | 2026-02-26 | MAZELSKY JONATHAN JAY C-suite | SELL | $662K |
| ◆ insider | 2026-02-26 | MAZELSKY JONATHAN JAY C-suite | SELL | $1.7M |
| ◆ insider | 2026-02-17 | Vandebroek Sophie V. Director | SELL | $594K |
| ◆ insider | 2026-02-17 | Vandebroek Sophie V. Director | SELL | $326K |
| ◆ insider | 2026-02-17 | Erickson Michael G Other | SELL | $284K |
| ◆ insider | 2026-02-17 | Erickson Michael G Other | SELL | $128K |
| ◆ insider | 2026-02-17 | Erickson Michael G Other | SELL | $807K |
| ◆ insider | 2026-02-17 | Erickson Michael G Other | SELL | $1.7M |
FAQ Common questions
How much has Congress traded IDXX?
19 disclosed buys and 20 sells of IDXX (Idexx Laboratories Inc.) appear in official congressional financial disclosures.
Is it legal for members of Congress to trade IDXX?
Members of Congress may trade stocks but must disclose it under the STOCK Act. QuantCapitol tracks those public disclosures for transparency — nothing here is an accusation of wrongdoing or investment advice.
Where does this data come from?
Official US House Clerk and Senate electronic financial disclosures. Every trade links back to its original filing so you can verify it yourself.